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states representing severe, moderate and mild ED. The
ED-specific values from Scale 1 are transferred onto a
second “dead to perfect health” scale. Fifteen subjects
with ED and 25 adults without ED participated in pilot
testing the instrument. The 15 ED subjects participated in
additional domain ranking and content relevance exer-
cises, and were asked to suggest additional domains they
considered relevant to the HRQL impact of ED. Minor
modifications were made, and the resultant instrument
was implemented in a clinical trial of 160 ED subjects.
Full validation analysis of feasibility, reliability, respon-
siveness and validity is ongoing.
RESULTS: Initial analysis demonstrates the instrument is
feasible, with only 13% of subjects making errors in the
most complex step (Scale 1). Preliminary evidence sug-
gests that the instrument is valid, measuring what it
claims to measure, with one subject suggesting the addi-
tion of one domain. One domain deletion was suggested.
94% of subjects felt the domains and levels appropriately
assessed the impact of ED on HRQL. The marker states
(mild, moderate, and severe) were correctly ranked and
fully understood by 100% of subjects. Responsiveness is
currently being assessed.
CONCLUSIONS: A HRQL instrument, for use in ED
subjects, which combines disease-specific and preference-
based approaches, has been successfully developed, pilot
tested and is currently undergoing validation analysis.
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OBJECTIVE: To validate an acceptability questionnaire
for a vaginal ring contraceptive.
METHODS: A 21-item questionnaire was developed
covering: ease of use (ring/package); clarity of instruc-
tions; sexual comfort; menstruation; compliance, and sat-
isfaction. A total of 2393 women completed the ques-
tionnaire after 3, 6 and 12 months of using a vaginal
contraceptive (NuvaRing®, Organon, Oss, The Nether-
lands). The robustness and predictive value of the ques-
tionnaire were assessed using cycle three data. The qual-
ity of completed questionnaires, item content analysis,
construct validity, internal consistency reliability, known-
group validity, and predictive value were evaluated.
RESULTS: Excluding non-ordinal items, on average
0.6% of data was missing. Principle component analysis
of 15 ordinal items indicated that linked domains gave
consistent results. Hence, ‘ease of package use’ and ‘clar-
ity of instructions’ were combined. Item-convergent va-
lidity, the degree of correlation between two measures of
the same construct, was excellent for ‘ease of use’ and
‘satisfaction,’ moderate for ‘clarity of instructions’ and
‘sexual comfort’ and poor for ‘menstruation.’ Item-dis-
criminant validity, the uniqueness of information, was
excellent for all domains. Women without adverse events
and completers responded to the questionnaire most pos-
itively. The likelihood of early discontinuation was linked
to the occurrence of adverse events (odds ratio (OR)
2.42), and having started this method because of prob-
lems with other methods (OR 1.46). Factors predicting
continuation were: compliance; age over 30 years; child-
lessness, and positive evaluation of NuvaRing after three
months.
CONCLUSION: The acceptability questionnaire has
good psychometric properties and can predict early dis-
continuation of the method. The questionnaire could be
used in general practice to monitor user compliance.
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OBJECTIVES: Published cost-effectiveness literature re-
garding surgical devices and procedures should be valid,
useful, and transparent. Since users often need to be able
to substitute local costs or resource utilization into eco-
nomic models, publications need to disclose sufficient in-
formation about the methodology and costs of resources
used rather than simply aggregate or average cost per
case data. The primary objective of this study was to ex-
amine the extent of useful disclosure of reported dollars
per health-care resource (HCR) in surgery performed in
all patient populations. The secondary objective was to
determine the extent to which economic principles and
disclosure (i.e., validity) existed.
METHODS: “Dollars per HCR” were obtained from lit-
erature searches conducted in two databases using the
search terms “surgery”, “cost”, and “cost effectiveness”.
Mean, standard deviation, and confidence intervals were
determined for each type of HCR. All articles were indi-
vidually critiqued for internal and external validity based
on ten created problem categories.
RESULTS: After eliminating 122 articles that contained
no cost information or analysis, twenty-five percent of
138 articles contained usable dollars per HCR data. All
descriptive statistics will be reported for each category.
Over 74 percent of the articles were missing one or more
of the following definitions or disclosures: fixed versus
variable costs; dollars per HCR; perspective, and sensitiv-
ity analysis. The greatest number of articles was found to
have five problems, while the lowest number had one
problem. Lack of transparency was also evident.
CONCLUSIONS: Published cost-effective literature can-
not be relied on nor easily utilized due to the lack of
availability of dollars per HCR and the weak validity of
such literature. Relying on invalid and useless published
literature can lead to unwarranted conclusions and an in-
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ability to determine cost-effectiveness in specific settings.
While site-specific research will likely be necessary, so is
the need to critically evaluate such literature before
blindly using it for decision-making.
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OBJECTIVE: The Benign Prostate Enlargement-Partner
questionnaire (BPE-P) was initially developed to assess
the impact of patient’s Benign Prostatic Hyperplasia
(BPH) on his partner’s quality of life (QOL). The objec-
tive of this study was to adapt the BPE-P for use in the
clinical trial setting, and to linguistically validate the re-
sulting questionnaire in US, Spanish, Canadian English
and Canadian French subjects.
METHODS: The BPE-P was reworded to facilitate use in
a clinical trial, and reviewed by a multidisciplinary team
including clinicians, QOL experts, and linguists. This US
English version was translated according to standard
methodology: 2 forward translations, 1 reconciliation, 1
back-translation by a native English-speaker, 3-4 reviews
by independent bilingual experts, and final reconciliation
by a native-speaking language coordinator. Pilot testing
and cognitive debriefing interviews were performed with
a minimum of 10 subjects per language/country who
were partners of men with BPH.
RESULTS: The following changes were made to the
questionnaire prior to translation: a) recall period of 30
days was incorporated; b) questions were changed to past
tense to reflect the recall period; c) wording on problems
with sex life was changed to sexual satisfaction to better
suit the trial setting and to prevent a response floor effect;
d) responses to the sexual satisfaction and overall QOL
question were revised; e) sexual satisfaction question was
moved to the penultimate item on the scale to better suit
the flow of questions. No significant problems were de-
tected during translation. Subjects found the translations
and their content suitable and relevant to their situation.
The resulting instrument is now called the Benign Prostate
Enlargement-Partner Impact of Treatment scale (BPE-PIT)
to better reflect its adaptation to the clinical trial setting.
CONCLUSION: The BPE-PIT was successfully trans-
lated for use in an international clinical trial. Psychomet-
ric validation of this new instrument remains necessary.
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Urinary problems secondary to benign prostatic hyperpla-
sia (BPH) are found in 20 to 25% of the male population
over 50 years of age. This is thus a public health problem
with a number of diagnostic, therapeutic and economic
facets. The severity of the condition is assessed by the IPSS
score, a well-known and recognized questionnaire.
OBJECTIVE: To evaluate the impact of this male pathol-
ogy on the spouse as part of the growing importance at-
tached to the caregiver.
METHODS: As part of a cohort study conducted be-
tween October 2000 and March 2001, the GP gave the
patient two PFM (Patient Family Measurement) self-
questionnaires for himself and for his spouse. During the
consultation, 36.1% of the patients spontaneously com-
plained of sleep problems.
RESULTS: We are most interested in the impact of day-
time somnolence. The Epworth Scale was used to evaluate
this. The score observed in a control population with nor-
mal sleeping habits is 5.9. For the analysis, we used 482
patient questionnaires and 382 spouse questionnaires. The
rate of return of the spouse questionnaires (80%) was very
satisfactory. The risk of daytime somnolence for the pa-
tient increased with the severity of the urinary problems
with scores of 5.9, 6.4, and 8.9 on the PFM for slight,
moderate, and severe urinary problems respectively. Simi-
larly, for the spouses, the PFM score increased with in-
creasing severity: slight  4.7; moderate  5; severe  7.4.
There is therefore a significant risk of daytime somnolence
among spouses of patients with severe BPH.
CONCLUSION: As it is known that somnolence is re-
sponsible for a third of all road accidents, it is essential
for these patients to limit the severity of their pathology
by undergoing appropriate treatment.
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Urinary problems secondary to benign prostatic hyper-
plasia (BPH) are found in 20 to 25% of the population of
men over 50 years of age. This is therefore a public health
problem with a number of diagnostic, therapeutic and
economic facets. The severity of the problem is assessed
by the score obtained on the IPSS, a well-known and rec-
ognized questionnaire.
OBJECTIVE: As part of the growing importance at-
tached to the caregiver, it is interesting to evaluate the
consequences of this masculine pathology for the spouse.
